SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21157)5/19/1998 6:17:00 PM
From: LTK007  Respond to of 32384
 
Thanks,Henry.Excellent info(eom)



To: Henry Niman who wrote (21157)5/19/1998 6:24:00 PM
From: dwc  Respond to of 32384
 
I believe that TAP Pharmaceuticals is Abbott Labs in this country. THey are joint venturing with Takeda in Japan.



To: Henry Niman who wrote (21157)5/20/1998 2:07:00 PM
From: dwc  Respond to of 32384
 
Henry:

The big deal created over the ENMD drugs was tempered by the caveat that it would be a year before they could be tested on humans. This story (Post # 21157) seems to indicate that a sister drug is being used in human trials with limited success. Is this substance that far ahead in anti-angiogenesis?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News